Lineage Cell Therapeutics, Inc. (LCTX)
1.364
-0.07
(-4.62%)
USD |
NYAM |
May 07, 16:00
1.37
+0.01
(+0.44%)
After-Hours: 20:00
Lineage Cell Therapeutics Profit Margin (Quarterly) : 13.50% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| SIGA Technologies, Inc. | -143.1% |
| Pacira Biosciences, Inc. | 1.64% |
| Niagen Bioscience, Inc. | 12.21% |
| Strata Critical Medical, Inc. | 3.56% |
| Prime Medicine, Inc. | -5.50K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -119.1% |
| Return on Assets | -61.17% |
| Return on Invested Capital | -114.0% |
| Gross Profit Margin (Quarterly) | 96.19% |
| Operating Margin (Quarterly) | -99.09% |
| Return on Net Operating Assets | -118.9% |